We compared plasma concentrations of Aβ peptides, tau, and selected cytokines between adults with DS, adults with sAD, and controls age-matched to the group with DS to investigate molecular mechanisms relevant to the development of AD in DS using ultrasensitive assays. The gene discussed is MAPT; the disease is Alzheimer disease.